COMP <GO>
DBVT vs CADL // EV/EBITDA & P/E VALUATION
DBV Technologies S.A. (NASDAQ) VS. Candel Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: DBVT 2
— CADL 2
■ METRIC PARITY
LAST: $10.29 (-3.38%) • MKT CAP: $647.0M
valuation
—
LAST: $8.65 (-0.23%) • MKT CAP: $661.9M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DBVT VS. CADL)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | DBVT | CADL | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -18.81% | -5.88% | -12.93 | CADL | /fcf-yield <GO> |
| Operating Margin | -60.00% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 35.80% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.37 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 2/9 | +1.00 | DBVT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 39.7 | 37.7 | +1.98 | DBVT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $647.0M | $661.9M | -$14.9M | CADL | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | DBVT REV | CADL REV | DBVT GROSS % | CADL GROSS % | DBVT FCF | CADL FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.6M | $0 | — | — | -$121.7M | -$38.9M |
| FY 2024 | $4.2M | $0 | — | — | -$106.8M | -$27.0M |
| FY 2023 | $15.7M | $0 | — | — | -$79.7M | -$34.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
DBVT // BETA —
CADL // BETA —